Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC

Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0001062993-24-003167 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-02-14	2024-02-12	COLL	Kuhlmann Shirley R.	EVP, GC	A - Grant	$0.00	+76.6K	162.9K	+89%	$0
M	2024-02-14	2024-02-12	COLL	Kuhlmann Shirley R.	EVP, GC	F - Tax	$33.70	-31.8K	164.4K	-16%	-$1.07M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-12	A	A	33,247	$0.00	196,165	D	—	—	(F2) Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 33,247 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
2	Common	Common Stock	2024-02-12	A	A	43,400	$0.00	162,918	D	—	—	(F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
3	Common	Common Stock	2024-02-12	F	D	21,146	$33.70	175,019	D	—	—	(F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
4	Common	Common Stock	2024-02-12	F	D	10,610	$33.70	164,409	D	—	—	(F4) Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.